Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.14
+4.72 (1.98%)
AAPL  259.92
+4.51 (1.77%)
AMD  250.72
-0.59 (-0.24%)
BAC  52.08
+0.05 (0.11%)
GOOG  335.39
+1.80 (0.54%)
META  667.80
-4.56 (-0.68%)
MSFT  480.93
+10.65 (2.26%)
NVDA  189.42
+2.95 (1.58%)
ORCL  174.41
-8.03 (-4.40%)
TSLA  433.04
-2.16 (-0.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.